ALLOGENE THERAPEUTICS INC
ALLO·019770106·US·Common Stock·Healthcare - Biotechnology-Activist
ALLO (ALLOGENE THERAPEUTICS INC) is held by 118 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($46.6M), STATE STREET CORP ($21.1M), PRIMECAP MANAGEMENT CO/CA/ ($20.4M). Net institutional sentiment: Bullish.
118
Holders
(12 Elite)
$291.9M
Total Value
71% (112)
Consensus
80 buying - 32 selling
13F: Insider & Congress:
Who's Trading
ActivistLYLynx1 Capital Management LP0.0%May 15, 2026
ActivistABArie Belldegrun, M.D.5.4%May 13, 2026
ActivistDDDavid D. Chang, M.D., Ph.D.4.9%May 13, 2026
ActivistFLFrazier Life Sciences Public Fund, L.P.4.7%Apr 23, 2026
InsiderYAYoshiyama AnnieSell $22KApr 21, 2026
InsiderBMBeneski Benjamin MachinasSell $7KMar 31, 2026
InsiderCDChang David DSell $118KMar 16, 2026
InsiderBMBeneski Benjamin MachinasSell $12KMar 16, 2026
InsiderBMBeneski Benjamin MachinasSell $19KMar 2, 2026
Showing 1-20 of 122
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer